Catalog No.:AA006LV3

90824-33-2 | 2-Hydrazinylbenzene-1-sulfonamide

Name: Name:2-Hydrazinylbenzene-1-sulfonamide
Brand: AABLOCKS
SKU: AA006LV3
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

50mg

95%

3 weeks

$286.00 $200.00

- +

100mg

95%

3 weeks

$368.00 $258.00

- +

250mg

95%

3 weeks

$477.00 $334.00

- +

500mg

95%

3 weeks

$683.00 $478.00

- +

95%

3 weeks

$843.00 $590.00

- +

2.5g

95%

3 weeks

$1,508.00 $1,055.00

- +

95%

3 weeks

$2,617.00 $1,832.00

- +

10g

95%

3 weeks

$4,831.00 $3,382.00

- +

Technical Information
Properties
Downstream Synthesis Route
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Downstream Synthesis Route
Literature

Technical Information

Catalog Number:

AA006LV3

Chemical Name:

2-Hydrazinylbenzene-1-sulfonamide

CAS Number:

90824-33-2

Molecular Formula:

C6H9N3O2S

Molecular Weight:

187.2196

MDL Number:

MFCD03093797

SMILES:

NNc1ccccc1S(=O)(=O)N

Properties

BP:

428.595°C at 760 mmHg

Storage:

Keep in dry area;2-8℃;

Computed Properties

Complexity:

234

Covalently-Bonded Unit Count:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Rotatable Bond Count:

XLogP3:

-0.1

Downstream Synthesis Route

methyl2-{3-(4-chlorophenyl)-5-oxo-4-(2S)-3,3,3-trifluoro-2-hydroxypropyl-4,5-dihydro-1H-1,2,4-triazol-1-yl}ethanimidate

36394-75-9

90824-33-2

(1S)-1-3-({3-(4-chlorophenyl)-5-oxo-4-(2S)-3,3,3-trifluoro-2-hydroxypropyl-4,5-dihydro-1H-1,2,4-triazol-1-yl}methyl)-1-(2-sulfamoylphenyl)-1H-1,2,4-triazol-5-ylethylacetate

[1]CurrentPatentAssignee:BAYERAG-WO2019/81302,2019,A1Locationinpatent:Page/Pagecolumn49;50

Literature

Title: Cloning, characterization and sulfonamide inhibition studies of an α-carbonic anhydrase from the living fossil sponge Astrosclera willeyana.

Journal: Bioorganic & medicinal chemistry 20120215

Title: Inhibition studies of the β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates.

Journal: Bioorganic & medicinal chemistry 20110815

Title: A new β-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth.

Journal: Bioorganic & medicinal chemistry 20110201

Title: Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata.

Journal: Bioorganic & medicinal chemistry letters 20110115

Title: Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Brucella suis.

Journal: Journal of medicinal chemistry 20100311

Title: Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides.

Journal: Bioorganic & medicinal chemistry 20090715

Title: Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides.

Journal: Bioorganic & medicinal chemistry 20071201

Title: Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.

Journal: Bioorganic & medicinal chemistry letters 20070701

Title: Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.

Journal: Journal of medicinal chemistry 20070125

Title: Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.

Journal: Bioorganic & medicinal chemistry letters 20060415

Title: Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.

Journal: Journal of medicinal chemistry 20060323

Title: Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors.

Journal: Journal of medicinal chemistry 20051201

Title: Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?

Journal: Bioorganic & medicinal chemistry letters 20050215

Title: Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.

Journal: Bioorganic & medicinal chemistry letters 20050215

Title: Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives.

Journal: Bioorganic & medicinal chemistry letters 20041115

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

SDS